Histamine H3 receptor-mediated inhibition of noradrenaline release in pig retina discs.
Discs of pig retina were preincubated with 3H-noradrenaline, 3H-dopamine or 3H-serotonin and then superfused. Electrical field stimulation increased the outflow of tritium from discs preincubated with 3H-noradrenaline or 3H-dopamine, but no from discs preincubated with 3H-serotonin. The tritium content at the end of superfusion was similar in discs preincubated with 3H-noradrenaline or 3H-dopamine but about tenfold lower in discs preincubated with 3H-serotonin. The tritium content in discs preincubated with 3H-noradrenaline was markedly reduced when desipramine was present during preincubation but was not affected by selective inhibitors of dopamine and serotonin uptake. The tritium content in discs preincubated with 3H-dopamine and 3H-serotonin, in contrast, was reduced or tended to be reduced by a selective dopamine and serotonin uptake inhibitor, respectively. The electrically evoked overflow of tritium from discs preincubated with 3H-noradrenaline was abolished by tetrodotoxin or omission of Ca2+. In discs superfused with desipramine, the electrically evoked overflow was enhanced by phentolamine but not affected by histamine. When both desipramine and phentolamine were present in the superfusion medium, histamine inhibited the evoked overflow (pIC15 6.85). This effect was mimicked by the histamine H3 receptor agonist R-(-)-alpha-methylhistamine as well as by its S-(+)-enantiomer (pIC15 7.85 and 5.30, respectively) but not by the H1 receptor agonist 2-(2-thiazolyl)ethylamine and the H2 receptor agonist dimaprit (each 10 mumol/l).(ABSTRACT TRUNCATED AT 250 WORDS)
Schlicker
E
E
Institut für Pharmakologie und Toxikologie, Rheinische Friedrich-Wilhelms-Universität, Bonn, Federal Republic of Germany.
Schunack
W
W
Göthert
M
M
D000818:Animals; D003891:Desipramine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004558:Electric Stimulation; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D008761:Methylhistamines / Q000494:pharmacology; D014179:Neurotransmitter Uptake Inhibitors / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism*; D010879:Piperazines / Q000494:pharmacology; D011814:Quipazine / Q000031:analogs & derivatives / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011968:Receptors, Histamine / Q000502:physiology*; D018100:Receptors, Histamine H3; D012160:Retina / Q000378:metabolism*; D012701:Serotonin / Q000494:pharmacology; D013552:Swine; D014316:Tritium
D008761:Methylhistamines; D014179:Neurotransmitter Uptake Inhibitors; D010879:Piperazines; D011968:Receptors, Histamine; D018100:Receptors, Histamine H3; D014316:Tritium; D012701:Serotonin; D011814:Quipazine; C031227:6-nitroquipazine; C043425:vanoxerine; D003891:Desipramine; D004298:Dopamine; D009638:Norepinephrine; C048140:N-methylhistamine